Mon, Dec 22, 2014, 5:09 PM EST - U.S. Markets closed


% | $
Quotes you view appear here for quick access.


  • hammond5 hammond5 May 23, 2006 1:37 PM Flag

    Concerns with IR

    I have done my best to explain to CMED IR that their job is to inform and manage their investors expectations. This is especially important with CMED because it is a new co, in a new field, promoting a new therapy, with NO long term verifications of that therapy. I am sorry to say they don't seem to be listening. I have asked many questions only to find out they answer only the ones they want to.
    If you pull up a 6 month chart and really objectively look at it you will see that the CMED stock price has been supported for a short time at the 40, then the 35, then the 30, then the 25, then the ? This is as large holdings at each level have been sold to the retail investor, that folks is US!
    I have never seen a company with the growth rates CMED claims sell this relentlessly. There ALWAYS turned out to be a reason for the selling that is not apparent to small investors during the process. This reason unfortunately causes terrible losses in one investment group. Guess which group we are in?
    I have one other major common sense concern. In light of the terrible tragedy that is in a cancer loss, some American company would be ALL OVER this therapy if it did what CMED claims. FDA crash course, fast track, et all.
    I wish you all the best, but, I believe there are better opportunities almost everywhere else.
    I am out.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • management recently reaffirmed y/y guidance and growth...

      im sorry, for your skepticism...its not justified in light of the press releases cmed has posted at yahoo and their own website...

      the story doesnt change on a day to day basis,,so why would management whip out press release after press release in order to soothe impatient investors such as yourself...

      It would take years if not a decade for an American company to get FDA approval for Hifu technology...CMED has already proven that Hifu technology is a successful viable product..As 20,000 patients have been successfully treated with hifu technology...Because of this,,CMED is far ahead any competitor in getting FDA approval...

      go ahead and put your money into another pfe and make 5% on your returns over the next several years...

      • 2 Replies to skywatcher384
      • sky--I agree with most of your post except for the last part. I bought PFE and it keeps going lower. I have sold some calls on the way down, but I'm still underwater. I would welcome a 5% return at this point. Ditto for my investment in CMED so far. But, I once held RIMM as it sunk lower and lower, and vowed that I would get my money back at the first opportunity RIMM gave me. Ouch! What a big mistake. Hoping CMED will be a similar story.

        Of course, it is not so much upcoming earnings that is the issue, as much as guidance at that time. If guidance confirms continued high growth rate, then CMED should finally take off. If that happens, most of us here are in a position to realize how undervalued we are and should be ahead of the curve in terms of buying more quickly before the crowd. If guidance disappoints, well...let's skip that for now. Good luck to you and other longs.

      • yu trust managnent over fukin prise chart akshen?? yu are a dope yu are lossing yore ass here

    • it showus they dont care abouwt yore fukin ass yu dope

3.400.0000(0.00%)Mar 13 1:43 PMEDT

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.